Published in Vaccine Weekly, July 8th, 1996
The protein, called decorin binding protein (DBP), was recently discovered in B. burgdorferi by Texas A&M, Houston, scientists and licensed exclusively to MedImmune. Data reported at the meeting suggested that as a Lyme disease vaccine candidate, DBP may provide advantages over outer surface protein A (OspA),...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.